Abstract:Targeted protein degradation (TPD) represents a potent chemical biology paradigm that leverages the cellular degradation machinery to pharmacologically eliminate specific proteins of interest. Although multiple E3 ligases have been discovered to facilitate TPD, there exists a compelling requirement to diversify the pool of E3 ligases available for such applications. This expansion will broaden the scope of potential protein targets, accommodating those with varying subcellular localizations and expression patterns. In this study, we describe a CRISPR-based transcriptional activation screen focused on human E3 ligases, with the goal of identifying E3 ligases that can facilitate heterobifunctional compound-mediated target degradation. This approach allows us to address the limitations associated with investigating candidate degrader molecules in specific cell lines that either lack or have low levels of the desired E3 ligases. Through this approach, we identified a candidate proteolysis-targeting chimera (PROTAC), 22-SLF, that induces the degradation of FKBP12 when the FBXO22 gene transcription is activated. 22-SLF induced the degradation of endogenous FKBP12 in a FBXO22-dependent manner across multiple cancer cell lines. Subsequent mechanistic investigations revealed that 22-SLF interacts with C227 and/or C228 in FBXO22 to achieve the target degradation. Finally, we demonstrated the versatility of FBXO22-based PROTACs by effectively degrading another endogenous protein BRD4. This study uncovers FBXO22 as an E3 ligase capable of supporting ligand-induced protein degradation through electrophilic PROTACs. The platform we have developed can readily be applied to elucidate protein degradation pathways by identifying E3 ligases that facilitate either small molecule-induced or endogenous protein degradation.

Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications

Targeting Cullin-RING Ubiquitin Ligases and the Applications in PROTACs

Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications

An in-cell approach to evaluate E3 ligases for use in targeted protein degradation.

Discovery of electrophilic degraders that exploit SNAr chemistry

ByeTAC: Bypassing an E3 Ligase for Targeted Protein Degradation

DCAF16-Based Covalent Handle for the Rational Design of Monovalent Degraders

Principles of paralog-specific targeted protein degradation engaging the C-degron E3 KLHDC2

Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16

Identification of KLHDC2 as an efficient proximity-induced degrader of K-RAS, STK33, β-catenin, and FoxP3

Investigating Protein Degradability through Site-Specific Ubiquitin Ligase Recruitment

A CRISPR activation screen identifies FBXO22 as an E3 ligase supporting targeted protein degradation

Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders

Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules

Leveraging dual-ligase recruitment to enhance degradation via a heterotrivalent PROTAC

Targeted Kinase Degradation via the KLHDC2 Ubiquitin E3 Ligase

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones

Bivalent Ligands for Protein Degradation in Drug Discovery

A covalent BTK ternary complex compatible with targeted protein degradation

IN SILICO DESIGN AND BINDING MECHANISM OF E3 LIGASE UBR1 RECRUITERS

Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation